南京伟思医疗科技股份有限公司2025年半年度报告摘要

Core Points - The company has decided to cancel its supervisory board and will allow the audit committee of the board to exercise the functions of the supervisory board as per the new Company Law [2][3] - The company will revise its Articles of Association to reflect this change and will also update related governance systems to enhance operational standards [5][6] - The changes will be submitted for approval at the upcoming shareholders' meeting, and the management team will be authorized to handle the necessary registration procedures [5][6] Company Overview - The company is named Nanjing Weisi Medical Technology Co., Ltd., with the stock code 688580 and the announcement number 2025-032 [2] - The company emphasizes the importance of maintaining compliance with legal regulations and protecting the interests of shareholders during the transition [3][4]